Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SCIATICA,GDF15,Growth/differentiation factor 15,Inverse variance weighted,2,0.85 [0.7-1.02],0.0732632503383854,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SCIATICA,EFNA4,Ephrin-A4,Inverse variance weighted,2,0.87 [0.69-1.08],0.206877511023296,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SCIATICA,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,2,0.91 [0.76-1.08],0.283507667291759,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SCIATICA,NEFL,Neurofilament light polypeptide,Inverse variance weighted,2,1.08 [0.89-1.32],0.439792185024278,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SCIATICA,CHGA,Chromogranin-A,Inverse variance weighted,2,0.92 [0.74-1.15],0.477647544344375,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SCIATICA,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,2,0.94 [0.75-1.16],0.543174047677796,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SCIATICA,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,2,0.94 [0.76-1.17],0.567867241885419,trans
Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SCIATICA,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Inverse variance weighted,2,0.96 [0.77-1.2],0.74535804684135,trans
